Breaking news

Ercheu: a conference on Alzheimer’s disease

Ercheu: a conference on Alzheimer’s disease
Ercheu: a conference on Alzheimer’s disease

Today, Tuesday September 21, World Alzheimer’s Day, a conference will be offered at the beginning of the afternoon at the Korian retirement home in Ercheu to explain how the place supports sick residents. “Korian houses promote non-drug therapies and the quality of life of people to fight against Alzheimer’s disease ”Says one at Korian France. The teams offer non-drug therapies such as play, adapted physical activity, animal mediation… With one goal: to slow the progression of the disease.

Non-drug therapies are offered based on the conclusions of the geriatric assessment carried out on entry into the establishment. Led by health professionals (doctor, nurse, psychologist, occupational therapist, psychomotor therapist, physiotherapist, etc.), they include a personalized program, regularly adapted to the evolution of the disease and the life history of the residents. They are divided into 3 therapeutic areas combined with one another: Functional therapies stimulate motor skills such as walking, balance, transfers, muscle strengthening, etc.; Cognitive therapies mobilize memory and knowledge and stimulate the different areas of the brain of language, memories… and Behavioral therapies reduce behavioral disorders and bring serenity to the resident. ” we continue.

“Alzheimer’s disease and those related to it are complex. The personality can evolve, with mood disorders in particular and a gradual loss of landmarks. Our expertise allows us to design and organize living spaces perfectly suited to people who suffer from it. Our caregivers are trained in care and are sensitized to the disease to adopt good interpersonal skills. They come together through their values ​​and their skills to surround people, s to make their daily life and those of their loved ones pleasant., emphasizes Fariba Kabirian, medical director of Korian in France.


Ercheu conference Alzheimers disease

For Latest Updates Follow us on Google News

PREV With the return of bronchiolitis, hospitals are under pressure again
NEXT »Noxxon Announces Planned Expansion of Phase 1/2 NOX-A12 Brain Cancer Trial MyPharma Editions